November 4, 2021
CDC recommends Pfizer/BioNTech pediatric COVID-19 vaccine
Editor's Note
The Centers for Disease Control and Prevention (CDC), on November 2, recommended broad use of the Pfizer/BioNTech COVID-19 vaccine for children ages 5 to 11.
Distribution of the vaccine to clinics, children’s hospitals, and pediatricians’ offices across the country have started, with plans to scale up to full capacity starting the week of November 8.
Free Daily News
- Higher MAP targets in acute spinal cord injury show no neurologic benefit, more complications
- Sports medicine procedures cost far less in ASCs than HOPDs
- Bariatric surgery outpaces GLP-1s in weight loss, cost savings
- Study finds overweight older adults have lower postsurgical mortality than peers with normal BMI
- FDA posts four device safety communications, prompting inventory, workflow checks
- 7 strategies healthcare leaders can use to turn around toxic workplace culture
- Nutrition screening tool predicts poor outcomes after pancreatic cancer surgery
- CDC reports 460% surge in drug-resistant NDM-CRE infections
- 5 reasons why perioperative leaders deserve to attend the 2025 OR Manager Conference
- Global medical community rejects Trump’s Tylenol-autism claims: Statements compilation
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement